These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 300150)

  • 21. Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters.
    Jersild C; Platz P; Thomsen M; Dupont B; Svejgaard A; Ciongoli AK; Fog T; Grob P
    Scand J Immunol; 1976; 5(1-2):141-8. PubMed ID: 178047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic aspects of multiple sclerosis.
    Taylor RS
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):525-36, v. PubMed ID: 9894106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological activity of blood lymphocyte fractions. A study by the macrophage electrophoretic mobility method.
    Minderhoud JM; Smith JK
    Clin Exp Immunol; 1972 Apr; 10(4):571-9. PubMed ID: 5034245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thoughts on the immunology of leprosy.
    Yahr MG
    Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):435-9. PubMed ID: 7009450
    [No Abstract]   [Full Text] [Related]  

  • 25. [Etiopathogenetic implications of viral infections during a course of multiple sclerosis: study of cellular immunity against measles and parotitis virus].
    Smeraldi E; Bottinelli S
    Acta Neurol (Napoli); 1973; 28(3):262-7. PubMed ID: 4732486
    [No Abstract]   [Full Text] [Related]  

  • 26. [Multiple sclerosis--an immunological disease].
    Vedeler CA
    Tidsskr Nor Laegeforen; 1991 Mar; 111(8):944-7. PubMed ID: 2042210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Developmental trends in neuroimmunology. 1: Principles, immuno-components, immunogenetics, contributions of virology].
    Meyer-Rienecker HJ
    Nervenarzt; 1984 Dec; 55(12):617-24. PubMed ID: 6441125
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunity in rheumatoid arthritis.
    Jiménez López A; Olmos Martínez JM
    Allergol Immunopathol (Madr); 1982; 10(6):471-9. PubMed ID: 6762823
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cellular immunity mediators in viral diseases (a review of the foreign literature)].
    Shepel' NG
    Veterinariia; 1978 Mar; (3):109-13. PubMed ID: 347691
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
    Tourbah A; Fontaine B; Lyon-Caen O
    Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Presentation of selected studies on the disease picture of multiple sclerosis].
    Schmidt RM; Neumann V; Kissig B; Kuppe G; Ludewig R
    Nervenarzt; 1987 Jul; 58(7):403-12. PubMed ID: 3498125
    [No Abstract]   [Full Text] [Related]  

  • 32. Lymphotoxin production in multiple sclerosis patients.
    Głabiński A; Pokoca L; Tchórzewski H; Selmaj K
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):285-90. PubMed ID: 1810221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defence systems of the body, immunosuppression and immunotherapy.
    James DG
    J R Nav Med Serv; 1976; 62(2):60-72. PubMed ID: 787517
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
    Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The immunology of multiple sclerosis: changing concepts].
    Vermersch P
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F138-46. PubMed ID: 18680832
    [No Abstract]   [Full Text] [Related]  

  • 36. [Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
    Zapadniuk BV; Kravets AS; Iarosh AA; Shurinok LA
    Vrach Delo; 1988 Aug; (8):84-6. PubMed ID: 3206892
    [No Abstract]   [Full Text] [Related]  

  • 37. [Multiple sclerosis: advances in its pathogenesis].
    Godoy J; Court J
    Rev Med Chil; 1982 Jun; 110(6):581-4. PubMed ID: 6761822
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-mediated hypersensitivity and disease activity in multiple sclerosis.
    Sheremata W; Cosgrove JB; Robb P
    Trans Am Neurol Assoc; 1973; 98():306-9. PubMed ID: 4784962
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lymphokines and monokines].
    Hamburger J; Dy M; Debray-Sachs M
    Ann Med Interne (Paris); 1980; 131(2):67-70. PubMed ID: 6156615
    [No Abstract]   [Full Text] [Related]  

  • 40. [The pathogenesis of multiple cerebrospinal sclerosis. Present state of knowledge and concepts (author's transl)].
    Jedlicka P
    Cas Lek Cesk; 1978 Apr; 117(15):449-53. PubMed ID: 350405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.